Simon Douglas

Simon Douglas

Presidente en FUSION ANTIBODIES PLC .

Fortuna: 112 980 $ al 31/07/2026

68 años
Health Technology
Commercial Services
Consumer Services

Perfil

Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
17/02/2026 861.062 ( 0,69 % ) 112 980 $ 31/07/2026

Cargos activos de Simon Douglas

EmpresasCargoInicio
FUSION ANTIBODIES PLC Presidente 01/09/2011
Presidente 01/09/2019

Antiguos cargos conocidos de Simon Douglas.

EmpresasCargoFin
Presidente 23/03/2026
CAMBRIDGE NUTRITIONAL SCIENCES PLC Presidente 22/04/2024
Director Ejecutivo 01/01/2019
Presidente 01/01/2011
Director Ejecutivo 01/01/2006
Ver el detalle de la experiencia de Simon Douglas.

Formación de Simon Douglas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

25

Relaciones de 1er grado

14

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas14

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Process Industries

Zeneca, Inc.

Health Services

Finance

Commercial Services

Technology Services

Health Technology

DRI Ltd. (United Kingdom)